These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 23459024)

  • 1. The influence of family ties on men's prostate cancer screening, biopsy, and treatment decisions.
    Shaw EK; Scott JG; Ferrante JM
    Am J Mens Health; 2013 Nov; 7(6):461-71. PubMed ID: 23459024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Younger British men's understandings of prostate cancer: A qualitative study.
    Grogan S; Parlane VL; Buckley E
    J Health Psychol; 2017 May; 22(6):743-753. PubMed ID: 26537520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Information needs of men regarding prostate cancer screening and the effect of a brief decision aid.
    Sheridan SL; Felix K; Pignone MP; Lewis CL
    Patient Educ Couns; 2004 Sep; 54(3):345-51. PubMed ID: 15324986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "It's a maybe test": men's experiences of prostate specific antigen testing in primary care.
    Evans R; Edwards AG; Elwyn G; Watson E; Grol R; Brett J; Austoker J
    Br J Gen Pract; 2007 Apr; 57(537):303-10. PubMed ID: 17394734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer support groups, health literacy and consumerism: are community-based volunteers re-defining older men's health?
    Oliffe JL; Bottorff JL; McKenzie MM; Hislop TG; Gerbrandt JS; Oglov V
    Health (London); 2011 Nov; 15(6):555-70. PubMed ID: 21177714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer screening in men with a family history of prostate cancer: the role of partners in influencing men's screening uptake.
    Meiser B; Cowan R; Costello A; Giles GG; Lindeman GJ; Gaff CL
    Urology; 2007 Oct; 70(4):738-42. PubMed ID: 17991547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer.
    Davison BJ; Oliffe JL; Pickles T; Mroz L
    Oncol Nurs Forum; 2009 Jan; 36(1):89-96. PubMed ID: 19136342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing men's decisions regarding prostate cancer screening: a qualitative study.
    Ferrante JM; Shaw EK; Scott JG
    J Community Health; 2011 Oct; 36(5):839-44. PubMed ID: 21336996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of the use of alternative therapies by men with localized prostate cancer.
    Steginga SK; Occhipinti S; Gardiner RA; Yaxley J; Heathcote P
    Patient Educ Couns; 2004 Oct; 55(1):70-7. PubMed ID: 15476992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'What is this active surveillance thing?' Men's and partners' reactions to treatment decision making for prostate cancer when active surveillance is the recommended treatment option.
    O'Callaghan C; Dryden T; Hyatt A; Brooker J; Burney S; Wootten AC; White A; Frydenberg M; Murphy D; Williams S; Schofield P
    Psychooncology; 2014 Dec; 23(12):1391-8. PubMed ID: 24830805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediated decision support in prostate cancer screening: a randomized controlled trial of decision counseling.
    Myers RE; Daskalakis C; Kunkel EJ; Cocroft JR; Riggio JM; Capkin M; Braddock CH
    Patient Educ Couns; 2011 May; 83(2):240-6. PubMed ID: 20619576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer.
    Davison BJ; Goldenberg SL
    BJU Int; 2011 Dec; 108(11):1787-93. PubMed ID: 21507187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What influences men's decision to have a prostate-specific antigen test? A qualitative study.
    Rai T; Clements A; Bukach C; Shine B; Austoker J; Watson E
    Fam Pract; 2007 Sep; 24(4):365-71. PubMed ID: 17644829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Connections Between Work, Prostate Cancer Screening, Diagnosis, and the Decision to Undergo Radical Prostatectomy.
    Yu Ko WF; Oliffe JL; Johnson JL; Bottorff JL
    Am J Mens Health; 2018 Sep; 12(5):1670-1680. PubMed ID: 29938564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shared decision making for prostate cancer screening: the results of a combined analysis of two practice-based randomized controlled trials.
    Sheridan SL; Golin C; Bunton A; Lykes JB; Schwartz B; McCormack L; Driscoll D; Bangdiwala SI; Harris RP
    BMC Med Inform Decis Mak; 2012 Nov; 12():130. PubMed ID: 23148458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Men's attitudes towards chlamydia screening: a narrative review.
    Balfe M; Brugha R; O'Connell E; Vaughan D; O'Donovan D
    Sex Health; 2012 May; 9(2):120-30. PubMed ID: 22498155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of significant others in complementary and alternative medicine decisions by cancer patients.
    Ohlén J; Balneaves LG; Bottorff JL; Brazier AS
    Soc Sci Med; 2006 Sep; 63(6):1625-36. PubMed ID: 16725245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender relations and couple negotiations of British men's food practice changes after prostate cancer.
    Mróz LW; Robertson S
    Appetite; 2015 Jan; 84():113-9. PubMed ID: 25305464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How underlying patient beliefs can affect physician-patient communication about prostate-specific antigen testing.
    Farrell MH; Murphy MA; Schneider CE
    Eff Clin Pract; 2002; 5(3):120-9. PubMed ID: 12088291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study of men's psychological and decision-related adjustment after treatment for localized prostate cancer.
    Steginga SK; Occhipinti S; Gardiner RA; Yaxley J; Heathcote P
    Urology; 2004 Apr; 63(4):751-6. PubMed ID: 15072894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.